bml 190 and piperidines

bml 190 has been researched along with piperidines in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
New, DC; Wong, YH	1
Bissonnette, CJ; Klegeris, A; McGeer, PL	1

Other Studies

2 other study(ies) available for bml 190 and piperidines

Article	Year
BML-190 and AM251 act as inverse agonists at the human cannabinoid CB2 receptor: signalling via cAMP and inositol phosphates. FEBS letters, 2003, Feb-11, Volume: 536, Issue:1-3 Topics: Cell Line; Colforsin; Cyclic AMP; Dose-Response Relationship, Drug; Drug Synergism; Humans; Indomethacin; Inositol Phosphates; Ligands; Morpholines; Piperidines; Pyrazoles; Receptors, Cannabinoid; Receptors, Drug; Second Messenger Systems	2003
Reduction of human monocytic cell neurotoxicity and cytokine secretion by ligands of the cannabinoid-type CB2 receptor. British journal of pharmacology, 2003, Volume: 139, Issue:4 Topics: Astrocytes; Camphanes; Cannabinoid Receptor Modulators; Cannabinoids; Cell Line; Cytokines; Dronabinol; Formazans; Gene Expression; Humans; Indoles; Indomethacin; L-Lactate Dehydrogenase; Ligands; Microglia; Monocytes; Morpholines; Nerve Degeneration; Neurotoxicity Syndromes; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Reverse Transcriptase Polymerase Chain Reaction; Rimonabant; RNA, Messenger; Temporal Lobe; Tetrazolium Salts	2003

Article

Year

BML-190 and AM251 act as inverse agonists at the human cannabinoid CB2 receptor: signalling via cAMP and inositol phosphates.

FEBS letters, 2003, Feb-11, Volume: 536, Issue:1-3

Topics: Cell Line; Colforsin; Cyclic AMP; Dose-Response Relationship, Drug; Drug Synergism; Humans; Indomethacin; Inositol Phosphates; Ligands; Morpholines; Piperidines; Pyrazoles; Receptors, Cannabinoid; Receptors, Drug; Second Messenger Systems

2003

Reduction of human monocytic cell neurotoxicity and cytokine secretion by ligands of the cannabinoid-type CB2 receptor.

British journal of pharmacology, 2003, Volume: 139, Issue:4

Topics: Astrocytes; Camphanes; Cannabinoid Receptor Modulators; Cannabinoids; Cell Line; Cytokines; Dronabinol; Formazans; Gene Expression; Humans; Indoles; Indomethacin; L-Lactate Dehydrogenase; Ligands; Microglia; Monocytes; Morpholines; Nerve Degeneration; Neurotoxicity Syndromes; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Reverse Transcriptase Polymerase Chain Reaction; Rimonabant; RNA, Messenger; Temporal Lobe; Tetrazolium Salts

2003